Invasive fungal infections (IFIs) can complicate the clinical course of COVID-19 and are
associated with a significant increase in mortality, especially in critically ill patients admitted …

Background Current guidelines recommend empirical antifungal therapy in patients with
sepsis with high risk of invasive Candida infection. However, many different risk factors have …

Sepsis is life-threatening organ dysfunction caused by a dysregulated host response to
infection (1). Sepsis and septic shock are major healthcare problems, impacting millions of …

It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

Purpose A systematic epidemiological study on intensive care unit (ICU)-acquired
candidemia across India. Method A prospective, nationwide, multicentric, observational …

Purpose To analyze trends in incidence and mortality of candidemia in intensive care units
(ICUs) vs. non-ICU hospitalized patients and to determine risk factors for infection by specific …

The echinocandin class of antifungal agents is considered to be the first-line treatment of
bloodstream infections (BSI) due to Candida glabrata. Recent reports of BSI due to strains of …

Invasive fungal infections are a growing problem in critically ill patients and are associated
with increased morbidity and mortality. Most of them are due to Candida species, especially …

The incidence of candidemia in the overall population ranges from 1.7 to 10 episodes per
100,000 inhabitants and Candida is one of the ten leading causes of bloodstream infections …

Introduction Over 5,000 cases of invasive Candida species infections occur in the United
Kingdom each year, and around 40% of these cases occur in critical care units. Invasive …